Functional Neuroimaging of Opioid Effects on Affective Experience
阿片类药物对情感体验影响的功能神经影像学
基本信息
- 批准号:7556543
- 负责人:
- 金额:$ 22.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-09-30 至 2010-05-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAddressAffectAffectiveAmygdaloid structureAnimalsAnteriorAnxietyAreaAttenuatedBase of the BrainBehaviorBehavioralBlinkingBrainBrain imagingBrain regionCollaborationsCrossover DesignDataDisciplineDistressDoseDouble-Blind MethodDrug AddictionDrug PrescriptionsDrug abuseElectromyographyEmotionalEmotionsExhibitsFaceFeelingFrightFunctional Magnetic Resonance ImagingFutureGoalsHumanImageImaging TechniquesIndividualIngestionInsula of ReilInternationalKnowledgeMagnetic Resonance ImagingMeasuresMediatingModelingMoodsMusNucleus AccumbensOpiate AddictionOpioidOpioid ReceptorOxycodonePainPatient Self-ReportPersonal SatisfactionPharmaceutical PreparationsPhysiologicalPlacebo ControlPlacebosPlayPopulations at RiskPsychotropic DrugsPublic HealthRandomizedRangeRateRelative (related person)ResearchRewardsRiskRoleSignal TransductionSiteStimulusSystemTechnologyTestingThinkingTimeVentral StriatumWell in selfaddictionaffective neurosciencebasebiological adaptation to stressblood oxygen level dependentcingulate cortexconceptdensitydispleasuredrug abuserdrug of abuseemotional distressemotional experienceexperiencehealthy volunteerhuman studyimprovednegative moodneural circuitneuroimagingneuromechanismneurotransmissionopioid abusepleasurepositive moodprescription documentprescription drug abuseprescription procedurepreventrelating to nervous systemresponse
项目摘要
DESCRIPTION (provided by applicant): There has recently been a marked increase in abuse and addiction of prescription opioid medications in the U.S., with costly public health consequences. Opioids, such as oxycodone, tend produce feelings of well-being and pleasure (e.g. 'high', elation), and may also reduce negative affect (e.g., relieve emotional distress, relieve anxiety), which may underlie the motives for abuse of opioid prescription drugs. Emerging evidence from affective neuroscience shows that limbic brain regions (e.g., ventral striatum [VS] / nucleus accumbens [NAcc], amygdala) play a pivotal role in the control of emotional experience and motivational behaviors in animals and humans. Interestingly, these regions contain a high density of opioid receptors, and have been posited as critical sites for the reinforcing effects of drugs of abuse. However, the effects of opioid medications on affective experience and emotion-related limbic function in humans are largely unknown. In this study, we propose to evoke positive and negative affect in healthy volunteers using pictures with emotional (and non- emotional/neutral) content. Positive and negative images are associated with increased activity in the VS/NAcc and amygdala, respectively. Our primary aim is to examine if oxycodone changes affective experience and affect-related activation in these limbic brain regions. Subjective affective experience will be measured by self- report ratings of affective valence (ranging from displeasure to pleasure), and limbic brain activity (in the VS / NAcc, amygdala) will be measured by the Blood Oxygenation-Level Dependent (BOLD) signal using functional magnetic resonance imaging (fMRI). These measures will be collected in real-time as subjects are viewing the emotionally-evocative pictures across 3 behavioral-fMRI sessions in a within-subjects, double-blind, randomized, placebo-control, dose-response crossover design following ingestion of placebo (PBO), 10mg, and 20mg of oxycodone. In this project, we bridge the accumulated knowledge and technology from human drug abuse research and brain imaging studies of emotion and affective experience, to test specific hypotheses about the acute effects of an opioid medication with substantial abuse potential on affective experience and associated mesolimbic brain activation. The proposed research directly addresses both the affective/mood-related mechanisms and the neural mechanisms of potential drugs of abuse, to understand why these drugs are misused and abused in nonmedical contexts. Such proof-of-concept findings derived from this study will generate hypotheses for future studies to be conducted in individuals who abuse (or are at risk for abusing) prescription opioid medications. Moreover, the neuroimaging project establishes a network of cross-disciplinary collaboration that will generate findings to support a larger-scale project involving prescription drug abusers or populations at risk for prescription drug abuse. Abuse of prescription pain relievers, such as opioid prescription medications, is a growing public health problem in the U.S. The goal of this project is to examine the effects of oxycodone, one of the more widely abused pain relievers, on mood and on the brain, in order to identify an explanation on why these drugs are being misused, which can help us prevent or treat opioid addiction.
描述(由申请人提供):最近美国处方阿片类药物的滥用和成瘾现象显着增加,造成了代价高昂的公共卫生后果。阿片类药物,如羟考酮,往往会产生幸福感和愉悦感(例如“兴奋”、兴高采烈),也可能减少负面影响(例如缓解情绪困扰、缓解焦虑),这可能是滥用阿片类处方药的动机。来自情感神经科学的新证据表明,边缘脑区域(例如,腹侧纹状体 [VS]/伏隔核 [NAcc]、杏仁核)在动物和人类的情绪体验和动机行为的控制中发挥着关键作用。有趣的是,这些区域含有高密度的阿片受体,并被认为是增强滥用药物作用的关键部位。然而,阿片类药物对人类情感体验和情绪相关边缘功能的影响在很大程度上尚不清楚。在这项研究中,我们建议使用带有情感(和非情感/中性)内容的图片来唤起健康志愿者的积极和消极影响。正像和负像分别与 VS/NAcc 和杏仁核的活动增加相关。我们的主要目的是检查羟考酮是否改变这些边缘脑区域的情感体验和情感相关激活。主观情感体验将通过情感效价的自我报告评级(范围从不高兴到快乐)来测量,边缘脑活动(在 VS / NAcc、杏仁核中)将通过使用功能磁共振成像(fMRI)的血氧水平依赖性(BOLD)信号来测量。这些测量值将在受试者在摄入安慰剂 (PBO)、10 毫克和 20 毫克羟考酮后,在受试者内、双盲、随机、安慰剂对照、剂量反应交叉设计中观看 3 个行为功能磁共振成像会话中的情绪唤起图片时实时收集。在这个项目中,我们将人类药物滥用研究和情感和情感体验的脑成像研究中积累的知识和技术联系起来,以测试有关阿片类药物对情感体验和相关中脑边缘大脑激活具有重大滥用潜力的急性影响的具体假设。拟议的研究直接解决潜在滥用药物的情感/情绪相关机制和神经机制,以了解为什么这些药物在非医疗环境中被误用和滥用。这项研究得出的概念验证结果将为未来在滥用(或有滥用风险)处方阿片类药物的个体中进行的研究提供假设。此外,神经影像项目建立了一个跨学科合作网络,该网络将产生研究结果来支持涉及处方药滥用者或有处方药滥用风险人群的更大规模项目。处方止痛药(例如阿片类处方药)的滥用是美国日益严重的公共卫生问题。该项目的目标是检查羟考酮(最广泛滥用的止痛药之一)对情绪和大脑的影响,以便找出这些药物被滥用的原因,这可以帮助我们预防或治疗阿片类药物成瘾。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Opioid modulation of resting-state anterior cingulate cortex functional connectivity.
- DOI:10.1177/0269881114548436
- 发表时间:2014-12
- 期刊:
- 影响因子:0
- 作者:Gorka SM;Fitzgerald DA;de Wit H;Angstadt M;Phan KL
- 通讯作者:Phan KL
Effects of oxycodone on brain responses to emotional images.
- DOI:10.1007/s00213-014-3592-4
- 发表时间:2014-11
- 期刊:
- 影响因子:3.4
- 作者:Wardle MC;Fitzgerald DA;Angstadt M;Rabinak CA;de Wit H;Phan KL
- 通讯作者:Phan KL
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
K. Luan Phan其他文献
K. Luan Phan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('K. Luan Phan', 18)}}的其他基金
Negative Valence Brain Targets and Predictors of Anxiety and Depression Treatment
负价大脑目标和焦虑和抑郁治疗的预测因子
- 批准号:
9086429 - 财政年份:2013
- 资助金额:
$ 22.8万 - 项目类别:
Negative Valence Brain Targets and Predictors of Anxiety and Depression Treatment
负价大脑目标和焦虑和抑郁治疗的预测因素
- 批准号:
8875269 - 财政年份:2013
- 资助金额:
$ 22.8万 - 项目类别:
Negative Valence Brain Targets and Predictors of Anxiety and Depression Treatment
负价大脑目标和焦虑和抑郁治疗的预测因子
- 批准号:
8573679 - 财政年份:2013
- 资助金额:
$ 22.8万 - 项目类别:
Cannabinoid Control of Fear Extinction Neural Circuits In Humans
大麻素对人类恐惧消退神经回路的控制
- 批准号:
8239686 - 财政年份:2012
- 资助金额:
$ 22.8万 - 项目类别:
Cannabinoid Control of Fear Extinction Neural Circuits In Humans
大麻素对人类恐惧消退神经回路的控制
- 批准号:
8470712 - 财政年份:2012
- 资助金额:
$ 22.8万 - 项目类别:
NEURO-GENETIC MARKERS OF SOCIAL ANXIETY DISORDER
社交焦虑症的神经遗传标志物
- 批准号:
7604782 - 财政年份:2007
- 资助金额:
$ 22.8万 - 项目类别:
Neuro-Genetic Markers of SSRI Treatment Response in Social Anxiety Disorder
社交焦虑症 SSRI 治疗反应的神经遗传标志物
- 批准号:
7618771 - 财政年份:2006
- 资助金额:
$ 22.8万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 22.8万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 22.8万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 22.8万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 22.8万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 22.8万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 22.8万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 22.8万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 22.8万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 22.8万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 22.8万 - 项目类别:
Research Grant